Andres et al. demonstrated that overexpression of 5-oxoprolinase, which reduces 5-Oxoproline (pyroglutamate) concentration, could improve cardiac function post-myocardial infarction in mice. This evidence concerns the gene OPLAH and myocardial infarction.